Vertex Pharmaceuticals Incorporated company logo
Vertex Pharmaceuticals Incorporated logo

VRTX Cash From Operations

Annual CFO

-$492.60M$4.03B-113.93%

Summary

Current Value
As of today, VRTX annual cash from operations is -$492.60M, down -113.93% on
Historical Performance
VRTX annual cash from operations is down -118.63% over the past 3 years, and down -131.39% over the past 5 years
All-Time High Comparison
VRTX annual cash from operations is currently -111.93% below its historical high of $4.13B set on
3-Year Low Comparison
VRTX annual cash from operations is at its 3-year low
Sector Comparison
VRTX annual cash from operations is higher than 0.76% of companies in Healthcare sector

Cash From Operations Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

VRTX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Operations-$492.60M-113.9%-118.6%-131.4%-15.2%
Quarterly Cash From Operations$1.24B-9.4%+29.9%+36.8%+857.0%
TTM Cash From Operations$3.72B+541.3%-8.1%+15.9%+750.4%
Price$460.59+11.4%+53.0%+102.8%+1094.8%
Annual Cash From Investing-$3.77B-20.0%-1005.9%-205.2%-641.1%
Annual Cash From Financing-$1.49B-165.9%-1.1%-1279.2%-249.6%
Annual Free Cash Flow-$978.00M-129.8%-140.6%-165.5%-116.8%
Annual CAPEX$485.40M+87.8%+106.5%+543.3%+1965.9%
Annual Net Income-$535.60M-114.8%-122.9%-145.5%+16.6%

Cash From Operations Highs

VRTX Annual Cash From Operations Highs Comparison
PeriodHighDateCurrent
3Y$4.13BN/A-111.9%
5Y$4.13B-111.9%
All$4.13B-111.9%

Cash From Operations Lows

VRTX Annual Cash From Operations Lows Comparison
PeriodLowDateCurrent
3Y-$492.60Mat low
5Y-$492.60Mat low
All-$635.44M+22.5%

Cash From Operations History

YearValueChange
-$492.60M-113.9%
$3.54B-14.3%
$4.13B+56.2%
$2.64B-18.7%
$3.25B+107.3%
$1.57B+23.5%
$1.27B+50.3%
$844.94M+257.9%
$236.10M+164.6%
-$365.43M+28.8%
-$513.20M-895.2%
-$51.57M-119.3%
$267.84M+86.3%
$143.74M+122.6%
-$635.44M-48.6%
-$427.59M-88.8%
-$226.48M+10.3%
YearValueChange
-$252.48M-1,023.4%
-$22.48M+86.9%
-$172.07M-21.0%
-$142.16M+15.2%
-$167.62M-110.7%
-$79.54M-885.1%
-$8.07M+51.5%
-$16.64M+47.7%
-$31.81M-2.4%
-$31.06M-231.7%
-$9.36M+76.7%
-$40.25M-152.4%
-$15.95M-8.6%
-$14.68M-270.1%
$8.63M+262.0%
-$5.33M-111.1%
-$2.52M-

FAQ

  • What is the current annual cash from operations of VRTX?

    As of today, VRTX annual cash from operations is -$492.60M

  • What is 1-year change in VRTX annual cash from operations?

    VRTX annual cash from operations is down -113.93% year-over-year

  • What is 3-year change in VRTX annual cash from operations?

    VRTX annual cash from operations is down -118.63% over the past 3 years

  • How far is VRTX annual cash from operations from its all-time high?

    VRTX annual cash from operations is currently -111.93% below its historical high of $4.13B set on December 31, 2022

  • How does VRTX annual cash from operations rank versus sector peers?

    VRTX annual cash from operations is higher than 0.76% of companies in Healthcare sector

  • When is VRTX next annual earnings release?

    The next annual earnings release for VRTX is on

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

Data Sources & References

  1. VRTX Official Website www.vrtx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/875320/000087532025000232/0000875320-25-000232-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532025000053/0000875320-25-000053-index.htm
  4. VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
  5. VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx